Conformis, Inc. Regains Compliance with Nasdaq’s Minimum Bid Price Rule
30 Novembro 2022 - 6:30PM
Conformis, Inc. (NASDAQ:CFMS) announced today that it received a
letter from the Listing Qualifications Department of The NASDAQ
Stock Market (“NASDAQ”) on November 25, 2022 notifying Conformis
that, based on the closing bid price of Conformis’ common stock
having been $1.00 per share or greater on each of the trading days
from November 10, 2022 to November 23, 2022, Conformis has regained
compliance with Nasdaq Listing Rule 5550(a)(2) and the minimum bid
price deficiency matter previously disclosed by Conformis is now
closed.
As previously reported, Conformis was notified by NASDAQ on
December 31, 2021 that its common stock failed to maintain a
minimum bid price of $1.00 over the previous 30 consecutive
business days as required by the Listing Rules of The Nasdaq Stock
Market. To regain compliance, Conformis was required to maintain a
minimum closing bid price of $1.00 or more for at least 10
consecutive trading days. This requirement was met on November 23,
2022, the tenth consecutive trading day when the closing bid price
of the Company’s common stock was greater than $1.00.
About Conformis, Inc.Founded in
2004, Conformis is a medical technology company focused
on advancing orthopedic patient care and creating a world without
joint pain. Its product portfolio is designed to maximize surgeon
and patient choice by offering fully personalized solutions through
its Image-to-Implant® Platinum Services℠ Program as well as
data-informed, standardized solutions that combine many benefits of
personalization with the convenience and flexibility of an
off-the-shelf system. Conformis’ sterile, just-in-time,
Surgery-in-a-Box™ delivery system is available with all of its
implants and personalized, single-use
instruments. Conformis owns or exclusively in-licenses
issued patents and pending patent applications that cover
personalized implants and patient-specific instrumentation for all
major joints. For more information, visit www.conformis.com.
To receive future press releases via e-mail alerts, sign up
at ir.conformis.com.
CONTACTInvestor
contactir@conformis.com781.374.5598
Source: Conformis, Inc.
Conformis (NASDAQ:CFMS)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Conformis (NASDAQ:CFMS)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024